March 6, 2017 09:00 AM EST

TG Therapeutics shares rocket up on successful PhIII leukemia study, teeing up a shot at accelerated FDA OK

Shares of TG Therapeutics $TGTX rocketed up 64% this morning after the New York-based biotech reported that its lead cancer drug scored a

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

TG Ther­a­peu­tics shares rock­et up on suc­cess­ful PhI­II leukemia study, tee­ing up a shot at ac­cel­er­at­ed FDA OK